openPR Logo
Press release

Lung Infections Market : Size, Industry Trend and Forecast 2025

11-07-2017 08:33 AM CET | Health & Medicine

Press release from: TMR Research

Lung Infections Market : Size, Industry Trend and Forecast 2025

Lung Infections Market: Snapshot

The treatment for lung infections has conventionally been led by small molecule therapies. These therapies however, were aimed to treat the symptoms of lung infections, rather than the actual cause of the infection. This has led to the emergence of diverse treatment options, which differ in terms of their targets and their action mechanism. Many past cases exist, where a patient has been given a combination of drugs for the treatment of several lung issues. However, in recent times, the treatment options for lung infections have improved significantly This is in light of the extensive research and development carried by market players and contributed by government bodies. The extensive research in the field of lung infections treatment has led to the development of targeted therapies and novel therapies.

A key factor boosting the growth of the lung infections market is the decrease in the time for approval process of treatment drugs and therapies. This is encouraging more and more market players to come up with novel therapies and other treatment options, which in turn is boosting the growth of the lung infections market. Favorable reimbursement policies in many nations and an improvement in the healthcare infrastructure are helping the global lung infections market to grow even in the developing nations of Asia Pacific. A rise in the overall economy has led to an increase in the expenditure towards healthcare and this is also driving the demand for lung infections treatment options.

Request Sample Copy of the Report@ www.tmrresearch.com/sample/sample?flag=B&rep_id=103

Global Lung Infections Market: Overview

Lung infections are found in larger airways (bronchitis) or in smaller air sacs (pneumonia). In lung infections, pus and fluid get built up in the airways of the lung and make it difficult to breathe. They can affect people of all ages, but the elderly and the children are at high risk for developing lung infections. Etiologies for lung infections include virus, bacteria, and mycoplasma. Symptoms for lung infections include difficulty in breathing, fever, blue-colored lips, stomach pain, chest pain, headache, loss of appetite, and vomiting.

Common medical conditions that are caused primarily due to lung infections include asthma, chronic obstructive pulmonary disease, pneumonia, tuberculosis, lung cancer and cystic fibrosis. Lung infections can be diagnosed using blood tests, chest x-rays, chest magnetic resonance imaging, chest computed tomography scans, bronchoscopy and pulmonary function tests. Medication (antibiotics) and surgical treatment (lobectomy, chest tube insertion) are largely available across all regions to treat various lung infections.

Request TOC of the Report @ www.tmrresearch.com/sample/sample?flag=T&rep_id=103

Global Lung Infections Market: Drivers and Key Trends

The global geriatric population is growing at a rapid pace across and these people are at a high risk for developing lung infections. Thus, the rising geriatric population and growing prevalence of asthma, COPD, pneumonia and cystic fibrosis become the leading propellants of the global lung infections treatment market. The U.S. Census Bureau stated that the key segment of the U.S. population is geriatric demographic. According to the World Health Organization (WHO), the global geriatric population would increase from 524 mn in 2010 to around 2 bn by the end of 2050. The global geriatric population would grow also at a faster rate in developed countries such as the U.S., the U.K. and Japan.

Additionally, rising awareness among people about lung infections and successive technological advancements in diagnostic tests account for drivers of the global lung infections market. However, the market is currently being stifled by technological complexity and high costs associated with diagnostic procedures.

Global Lung Infections Market: Regional Analysis

North America dominates the global lung infections market due to a strong demand for diagnostic tests and a growing demand for lung infection treatments. The region also holds a very high level awareness among people, further backed by government initiatives. Europe similarly represents the key share in the global lung infections treatment market, owing to the presence of an exceptionally large geriatric population.

Get Discount @ www.tmrresearch.com/sample/sample?flag=D&rep_id=103

Asia Pacific is considered as a largely untapped market for lung infections treatments due to a lower diagnosis rate and the lack of proper healthcare facilities in a few Asian countries. This market will be fuelled over the coming years by the swiftly evolving healthcare infrastructure and increase in healthcare expenditure. Asia Pacific also accounts as a promising region in lung infections treatment demand due to a rising market penetration of commercially available solutions. The rest of the world holds the fourth position in the global lung infections treatment market due to poor economic and health conditions in key countries.

Global Lung Infections Market: Companies Mentioned in the Report

Leading market players in the global lung infections market for 2016 included Bayer AG, Insmed Incorporated, Creative Antibiotics Sweden AB, and Destiny Pharma Ltd.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.

Contact:

TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lung Infections Market : Size, Industry Trend and Forecast 2025 here

News-ID: 804644 • Views: 129

More Releases from TMR Research

Drivers and Restraints: Solar Water Disinfection Market Growth and Restrain Fact …
Global Solar Water Disinfection Market: Snapshot Solar water disinfection has emerged as one of the most practical methods and low-cost techniques used by over 6 million people world over to disinfect non-potable water. The zero intervention measure has gained popularity among rural populations and low-income areas, especially in developing nations, to purify drinking water. These areas are characterized by the poor access to water sources and the unavailability of adequate sanitation.
Global Industry Analysis : Power Substation Automation and Integration Market Re …
Global Power Substation Automation and Integration Market: Snapshot Smart grid infrastructures have fundamentally transformed the electric power industry in a number of developed and developing nations. They play a seminal role in power substation automation and integration and have increased implementation in the electric sector. They essentially consist of advanced control methods and modern system software infrastructure. Out of several components of smart grid, primary are smart sensing & metering technologies
Energy Management Systems (EMS) Market - Overview On Upcoming Need 2025 | C3 Ene …
Global Energy Management Systems (EMS) Market: Snapshot Energy management systems (EMS) consist of hardware and software control systems designed to monitor and manage energy consumption and usage in buildings. They are aimed to optimize the entire energy consumption process in buildings, improve the utilization of electrical system, and reduce utility costs. EMS include sensors and other automation systems to collect and analyze crucial data on processes pertaining to lighting, power, security
Artificial Lift Systems Market Worldwide Survey On Product Need 2025 | Sclumberg …
Global Artificial Lift Systems Market: Snapshot It has been observed that at some point in their workable life, almost all oil wells need artificial lift systems. Of the nearly 2 mn operational oil wells across the globe, more than 90% which require some variety of artificial lift system to transport hydrocarbon to the surface at economical prices. As production capacities of most mature oil wells decline over the years, many forms

All 25983 Releases


More Releases for Lung

Interstitial Lung Disease Therapeutics - Pipeline Analysis 2018
Interstitial lung disease is a type of inflammatory disease that affects and thickens the interstitium of the lungs. Download the sample report @ https://www.pharmaproff.com/request-sample/1126 The interstitium is a lace like network of the tissue that provide support to the air sacs and the capillaries in the interstitium which allows the gas exchange between the blood and alveolar tissues. Get the detailed analysis @ https://www.pharmaproff.com/report/interstitial-lung-disease-therapeutics-pipeline-analysis Some of the types of the condition include
Lung Cancer and Therapies Meet 2019
Lexis is the world best platform for all the researchers to showcase their on-going research work through Oral/Poster presentations in front of the international audience, provided with additional opportunities for expanding their research work by conducting workshops and by exhibiting products. It gives you the global exposure and helps to associate with the present and potential researchers who discover novel techniques to treat Lung Cancer with different approach. This meet enlightens
Acute Lung Injury Market Technological breakthroughs 2025
Acute lung injury (ALI) is commonly characterized by hypoxia, lung complication and pulmonary edema. This condition causes inflammation or direct injury to the lungs. Generally, the symptoms of this disease are divided into two forms namely, primary ALI and secondary ALI. Primary ALI is caused by the conditions like pneumonia. While, secondary ALI is mainly caused by indirect injury to the lungs. Inhalation injury, pulmonary contusions, sever trauma, shock are
Lung Cancer Treatment Market Outlook to 2022
Market Overview, Key in-line Products, Market Share Distribution, Competitive Dynamics, Regulatory Outlook, Pipeline Development, Growth Catalysts & Challenges, Leading Market & R&D Trends, Partnership & Deals Analyses, Global Sales forecast of in-line and pipeline products, Fast Growing Private Companies, Management Perspectives, Commentaries, Market Outlook & Summary Conclusions The global lung cancer drugs market was valued at $3.1bn in 2016 and is forecast to grow at a healthy 31.1% CAGR between 2016
04-28-2017 | Health & Medicine
TMR
Lung Cancer Therapeutics Market Research Report 2017
Abnormal cell growth can lead to cancer. Cells that grow uncontrollably invade nearby tissues and further spread to other parts of the body through the lymphatic system. Lung cancer, also known as lung carcinoma, is characterized by uncontrolled cell growth in lungs. There are three major types of lung cancer: non-small cell lung cancer, small cell lung cancer, and lung carcinoid tumor. Non-small cell lung cancer is the common type
Global Lung Cancer Therapeutics Market
The Lung Cancer Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Cancer is a disease of genes which are caused due to abnormal growth of cells. These abnormal cells further migrate from the original site to other site through blood and